Lantheus Holdings (LNTH) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research • 02/23/23
Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA LevelsGlobeNewsWire • 02/16/23
Lantheus: Wedging Up To Resistance, Testing Key Retracement Levels (Technical Analysis)Seeking Alpha • 02/16/23
Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern TimeGlobeNewsWire • 02/09/23
Lantheus to Present Piflufolastat F 18 Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers SymposiumGlobeNewsWire • 02/08/23
Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding Imaging Pipeline into Alzheimer's DiseaseGlobeNewsWire • 02/06/23
How Much Upside is Left in Lantheus Holdings (LNTH)? Wall Street Analysts Think 83.92%Zacks Investment Research • 01/24/23
Lantheus Holdings (LNTH) Crossed Above the 50-Day Moving Average: What That Means for InvestorsZacks Investment Research • 01/24/23
Down -8.54% in 4 Weeks, Here's Why You Should You Buy the Dip in Lantheus Holdings (LNTH)Zacks Investment Research • 01/06/23
Down -21.46% in 4 Weeks, Here's Why You Should You Buy the Dip in Lantheus Holdings (LNTH)Zacks Investment Research • 12/29/22
Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT BiopharmaGlobeNewsWire • 12/20/22
Lantheus Holdings (LNTH) Loses 10.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 12/09/22
Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027GlobeNewsWire • 12/06/22
Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior Notes due 2027GlobeNewsWire • 12/05/22
Wall Street Analysts Believe Lantheus Holdings (LNTH) Could Rally 64%: Here's is How to TradeZacks Investment Research • 12/02/22
Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, CommercialGlobeNewsWire • 11/29/22
3 Medical Products Stocks Navigating Industry Challenges (Revised)Zacks Investment Research • 11/24/22